AP NEWS

One Day Programme: An Essential Overview of the Pharmaceutical and Biotech Industries (London, United Kingdom - November 9th, 2018) - ResearchAndMarkets.com

September 20, 2018

DUBLIN--(BUSINESS WIRE)--Sep 20, 2018--The “An Essential Overview of the Pharmaceutical and Biotech Industries” conference has been added to ResearchAndMarkets.com’s offering.

This programme will give you an invaluable overview of the Pharmaceutical industry, from discovery of the molecule through development to marketing. It will provide a step by step understanding of the main areas of drug development and will discuss the roles and responsibilities of key staff involved. You will be given a comprehensive glossary of the most commonly used industry terms which will be an invaluable reference to help you get to grips with the technical terminology and jargon.

All those wanting to achieve a better understanding of how the Pharmaceutical Industry works. The course will be particularly helpful for those wanting to understand what other departments do, for new staff working in the industry and for non-scientific and administrative personnel.

Why you should attend

Increase your understanding of the Pharma industry Develop your knowledge of the stages of drug development from dug discovery through to marketing Get to grips with the phases of Clinical Trials, Regulatory Processes and Pharmacovigilance Requirements Understand the role and responsibilities of key department and how they work together Demystify the technical terminology and jargon

Agenda:

How the pharma/biotech industries develop medicines

Overview of drug development and why we patent drugs The difference between a pharmaceutical and biotechnology company Drug discovery Non-clinical/pre-clinical the importance of examining safety

Demystifying the jargon and terminology

What are the roles and responsibilities of the people in the pharma / biotech industries?

Clinical trials

Gaining a clear picture of what happens at each phase of clinical research: Phase I - Phase IV Ensuring the quality of the data: monitoring, auditing and working to ICH

Pharmacovigilance

What is pharmacovigilance? Overview of safety reporting, signal detection, evaluation and risk management

Regulatory processes

Overview of regulatory submissions and approval procedures, including EU accelerated procedures The importance of ICH The electronic Common Technical Document (eCTD) The EU Clinical Trial Regulation The impact of Brexit

How are medicines marketed and sold

For more information about this conference visit https://www.researchandmarkets.com/research/njjn8d/one_day?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180920005335/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biotechnology

KEYWORD: UNITED KINGDOM EUROPE

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/20/2018 06:00 AM/DISC: 09/20/2018 06:01 AM

http://www.businesswire.com/news/home/20180920005335/en

AP RADIO
Update hourly